2015年5月19日星期二

Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.

Products Name: Cinacalcet HCl
CAS NO.: 364782-34-3
Synonyms: N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride
Formula: C22H22F3N.HCl
Weight: 393.88
Structure:

Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease on dialysis.
Cinacalcet HCl is indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Cinacalcet HCl lowers serum calcium. Significant reductions in calcium may lower the threshold for seizures. Secondary hyperparathyroidism patients, particularly those with a history of a seizure disorder, should be carefully monitored for the occurrence of low serum calcium or symptoms of hypocalcemia. The most commonly reported side effects were nausea and vomiting.

Cinacalcet HCl is indicated for the treatment of secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) on dialysis.
HPT(hyperparathyroidism)
PTH(parathyrioidhomone)
(hypo-or adynamic bone disease,ABD)

2015年5月18日星期一

The 73rd China International Medical Equipment Fair

The 73rd China International Medical Equipment Fair
The 20th International Component Manufacturing & Design Show
Time: May 15-18, 2015
Venue:  National Exhibition and Convention Center, Shanghai
There will be so many manufactory for hemodialysis consumable to take part in the Fair.
Such as hemodialysis concentrate, blood line set, AV, Fistula Needle and also for the Dialyzer.